Updated Jul 16, 2026
Buell Jennifer has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Jennifer Buell is the Chief Executive Officer of MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing iNKT cell therapies. She has also held the position of Chairman Executive Council and has been involved in multiple SEC filings related to her roles.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-14 | INKT | MiNK Therapeutics, Inc. | F — Tax withholding / forfeiture | 10.0K | $11.12 | $111K |
| 2026-01-06 | INKT | MiNK Therapeutics, Inc. | A — Grant or award | 31.5K | $11.12 | $350K |
| 2025-09-09 | INKT | MiNK Therapeutics, Inc. | F — Tax withholding / forfeiture | 5.4K | $15.36 | $82K |
| 2025-05-02 | AGEN | AGENUS INC | A — Grant or award | 581 | $3.11 | $2K |
| 2025-04-18 | AGEN | AGENUS INC | A — Grant or award | 869 | $2.08 | $2K |
| 2025-04-04 | AGEN | AGENUS INC | A — Grant or award | 1.2K | $1.56 | $2K |
Jennifer Buell is the Chief Executive Officer of MiNK Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing iNKT cell therapies. She has also held the position of Chairman Executive Council and has been involved in multiple SEC filings related to her roles.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Buell Jennifer profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.